Asahi Life Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,062
Closed -$287K – 177
2026
Q1
$287K Sell
2,062
-228
-10% -$31.9K 0.19% 131
2025
Q4
$281K Buy
+2,290
New +$278K 0.16% 147
2024
Q2
– Sell
-6,810
Closed -$499K – 182
2024
Q1
$499K Buy
+6,810
New +$524K 0.3% 60
2023
Q4
– Sell
-6,160
Closed -$462K – 195
2023
Q3
$462K Buy
+6,160
New +$474K 0.16% 69
2023
Q1
– Sell
-6,340
Closed -$544K – 221
2022
Q4
$544K Buy
6,340
+1,050
+20% +$83.2K 0.18% 68
2022
Q3
$326K Sell
5,290
-2,510
-32% -$158K 0.1% 99
2022
Q2
$482K Sell
7,800
-760
-9% -$47.1K 0.13% 68
2022
Q1
$509K Buy
+8,560
New +$547K 0.07% 87
2021
Q3
– Sell
-4,200
Closed -$289K – 257
2021
Q2
$289K Buy
+4,200
New +$280K 0.04% 143
2021
Q1
– Sell
-10,360
Closed -$604K – 218
2020
Q4
$604K Buy
10,360
+1,470
+17% +$88.7K 0.08% 83
2020
Q3
$562K Buy
+8,890
New +$616K 0.08% 63
2020
Q2
– Sell
-10,790
Closed -$807K – 251
2020
Q1
$807K Sell
10,790
-18,483
-63% -$1.28M 0.14% 51
2019
Q4
$1.9M Sell
29,273
-6,950
-19% -$453K 0.28% 41
2019
Q3
$2.3M Buy
36,223
+7,457
+26% +$487K 0.37% 37
2019
Q2
$1.94M Buy
28,766
+14,166
+97% +$932K 0.39% 37
2019
Q1
$949K Buy
14,600
+2,000
+16% +$133K 0.16% 44
2018
Q4
$788K Buy
+12,600
New +$881K 0.12% 49

Other funds holding GILD

Asahi Life Asset Management's GILD Position: Q2 2026 in Review

Asahi Life Asset Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,062 shares — an estimated $287K sold.

Asahi Life Asset Management first reported a position in GILD in Q4 2018 and held it in 17 quarters. The position peaked at $2.3M in Q3 2019. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Asahi Life Asset Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Asahi Life Asset Management sold 2,062 Gilead Sciences shares in Q2 2026, an estimated $287K.
  • Asahi Life Asset Management first reported a position in Gilead Sciences in Q4 2018 and held it in 17 quarters.
  • Asahi Life Asset Management's Gilead Sciences position peaked at $2.3M in Q3 2019.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.